University of Minnesota develops cancer drug that helps dogs with hemangiosarcomaFebruary 14, 2017The University of Minnesota has announced the breakthrough trial of a new drug that improves survival rates in dogs diagnosed with a cancer called hemangiosarcoma (HSA). The research and results were published recently published in the journal of Molecular Cancer Therapeutics.
SPONSORED CONTENTThe clear reco for hidden stressOur therapeutic nutrition targets underlying stress in cats with GI or urinary issues — helping provide relief to pets and their humans. + Learn More